Novel proteomic characterization of multiple myeloma bone marrow interstitial fluid links prognosis to coagulation pathways
Our findings support the value of fluid-based proteomic assessment of MM and suggest that coagulation-related PGs could serve as valuable novel biomarkers for risk stratification in multiple myeloma, warranting further investigation into this area.
Authors
- Nicholas Forward
- J Pierre (ORCID: https://orcid.org/0000-0001-5525-6896)
- Darrell White (ORCID: https://orcid.org/0000-0002-1341-4160)
- Alfredo De La Torre
- Robert Liwski (ORCID: https://orcid.org/0000-0002-4796-9893)
- Sam Cutler
- Manal O. Elnenaei (ORCID: https://orcid.org/0000-0002-0986-4441)
- Daniel Gaston (ORCID: https://orcid.org/0000-0003-2841-8057)
- Amy M. Trottier (ORCID: https://orcid.org/0000-0001-9922-9232)
- J. G. Quinn (ORCID: https://orcid.org/0000-0002-6579-4185)
- Randy Veinotte
Institutions
- Dalhousie University (CA)
- Nova Scotia Health Authority (CA)
- Beatrice Hunter Cancer Research Institute (CA)
Publication Details
- Journal
- Clinical Proteomics
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s12014-025-09560-6
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dalhousie University